In retrospect, since the majority of NOTCH-induced genes in T-ALL are also targeted by MYC [58], it is perhaps not surprising to find that virtually all of the TLX1/NOTCH signature genes that we validated by qRT-PCR negatively responded to inhibition of MYC by compound 10058-F4 treatment. Here, MYC is linked to acute lymphoblastic leukemia.